P. Marathe

887 total citations
19 papers, 745 citations indexed

About

P. Marathe is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, P. Marathe has authored 19 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Oncology. Recurrent topics in P. Marathe's work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). P. Marathe is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). P. Marathe collaborates with scholars based in United States, Germany and India. P. Marathe's co-authors include Sandhya Mandlekar, W. Griffith Humphreys, Subrata Jana, Rashmi H. Barbhaiya, Wen Chyi Shyu, Yurong Lai, Hong Shen, Jungui Dai, Umesh Shukla and K Prabhakar and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Current Medicinal Chemistry and Drug Metabolism and Disposition.

In The Last Decade

P. Marathe

19 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Marathe United States 12 360 253 211 162 100 19 745
Leslie Z. Benet United States 16 330 0.9× 308 1.2× 277 1.3× 146 0.9× 131 1.3× 26 1.0k
Yong–Hae Han United States 19 584 1.6× 295 1.2× 307 1.5× 378 2.3× 98 1.0× 39 1.3k
Kazuya Ishida Japan 17 318 0.9× 179 0.7× 166 0.8× 157 1.0× 73 0.7× 50 703
Svein Øie United States 16 306 0.8× 240 0.9× 145 0.7× 368 2.3× 149 1.5× 45 982
Timothy J. Strelevitz United States 9 248 0.7× 402 1.6× 85 0.4× 237 1.5× 88 0.9× 13 722
Rhys Whomsley Belgium 17 153 0.4× 210 0.8× 244 1.2× 211 1.3× 118 1.2× 36 928
David L. Bourdet United States 14 317 0.9× 194 0.8× 160 0.8× 182 1.1× 75 0.8× 37 821
Aki T. Heikkinen Finland 18 317 0.9× 236 0.9× 114 0.5× 215 1.3× 81 0.8× 34 819
Sarah Kempshall United Kingdom 12 594 1.6× 385 1.5× 334 1.6× 192 1.2× 86 0.9× 13 1.0k
Mallé Jurima‐Romet Canada 17 289 0.8× 537 2.1× 161 0.8× 319 2.0× 120 1.2× 33 1.1k

Countries citing papers authored by P. Marathe

Since Specialization
Citations

This map shows the geographic impact of P. Marathe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Marathe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Marathe more than expected).

Fields of papers citing papers by P. Marathe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Marathe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Marathe. The network helps show where P. Marathe may publish in the future.

Co-authorship network of co-authors of P. Marathe

This figure shows the co-authorship network connecting the top 25 collaborators of P. Marathe. A scholar is included among the top collaborators of P. Marathe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Marathe. P. Marathe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Marathe, P., et al.. (2020). A review of clinical studies involving pregnant women registered in the Clinical Trials Registry of India. Perspectives in Clinical Research. 11(1). 8–8. 4 indexed citations
2.
Lai, Yurong, Sandhya Mandlekar, Hong Shen, et al.. (2016). Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition. Journal of Pharmacology and Experimental Therapeutics. 358(3). 397–404. 147 indexed citations
3.
Shen, Hong, Jungui Dai, Yaofeng Cheng, et al.. (2016). Coproporphyrins I and III as Functional Markers of OATP1B Activity: In Vitro and In Vivo Evaluation in Preclinical Species. Journal of Pharmacology and Experimental Therapeutics. 357(2). 382–393. 104 indexed citations
4.
Zhang, Yusheng, Young‐Hwan Han, Murali K. Matta, et al.. (2015). Diclofenac and Its Acyl Glucuronide: Determination of In Vivo Exposure in Human Subjects and Characterization as Human Drug Transporter Substrates In Vitro. Drug Metabolism and Disposition. 44(3). 320–328. 60 indexed citations
5.
Shen, Hong, Hualiang Jiang, Craig Titsch, et al.. (2015). Cynomolgus Monkey as a Clinically Relevant Model to Study Transport Involving Renal Organic Cation Transporters: In Vitro and In Vivo Evaluation. Drug Metabolism and Disposition. 44(2). 238–249. 29 indexed citations
6.
Sun, Qin, Timothy W. Harper, Elizabeth A. Dierks, et al.. (2011). 1-Aminobenzotriazole, a Known Cytochrome P450 Inhibitor, Is a Substrate and Inhibitor of N-Acetyltransferase. Drug Metabolism and Disposition. 39(9). 1674–1679. 34 indexed citations
7.
Jana, Subrata, Sandhya Mandlekar, & P. Marathe. (2010). Prodrug Design to Improve Pharmacokinetic and Drug Delivery Properties: Challenges to the Discovery Scientists. Current Medicinal Chemistry. 17(32). 3874–3908. 100 indexed citations
8.
Mandlekar, Sandhya, et al.. (2007). Development of anin vivorat screen model to predict pharmacokinetic interactions of CYP3A4 substrates. Xenobiotica. 37(9). 923–942. 23 indexed citations
9.
Marathe, P., Wen Chyi Shyu, & W. Griffith Humphreys. (2004). The Use of Radiolabeled Compounds for ADME Studies in Discovery and Exploratory Development. Current Pharmaceutical Design. 10(24). 2991–3008. 88 indexed citations
10.
Marathe, P., et al.. (2000). Pharmacokinetics and Bioavailability of a Metformin/Glyburide Tablet Administered Alone and with Food. The Journal of Clinical Pharmacology. 40(12). 1494–1502. 51 indexed citations
11.
Marathe, P., et al.. (1998). Assessment of effect of food, gender, and intra-subject variability in the pharmacokinetics of avitriptan. Biopharmaceutics & Drug Disposition. 19(3). 153–157. 11 indexed citations
12.
Marathe, P., et al.. (1998). Evaluation of the effect of food on the pharmacokinetics of avitriptan. Biopharmaceutics & Drug Disposition. 19(6). 381–394. 9 indexed citations
13.
Marathe, P., Douglas S. Greene, & Rashmi H. Barbhaiya. (1997). Disposition of [14C]avitriptan in rats and humans.. PubMed. 25(7). 881–8. 6 indexed citations
14.
Barbhaiya, Rashmi H., Umesh Shukla, Philip Chaikin, Douglas S. Greene, & P. Marathe. (1996). Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation. European Journal of Clinical Pharmacology. 50(1-2). 101–107. 16 indexed citations
15.
Marathe, P., Danny D. Shen, & Wendel L. Nelson. (1994). Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.. Drug Metabolism and Disposition. 22(2). 237–247. 16 indexed citations
16.
Shukla, Umesh, P. Marathe, Kelly Pittman, & Rashmi H. Barbhaiya. (1993). Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog.. Drug Metabolism and Disposition. 21(3). 502–507. 28 indexed citations
17.
Shukla, Umesh, P. Marathe, John A. Labudde, Kelly Pittman, & Rashmi H. Barbhaiya. (1992). Pharmacokinetics of nefazodone in the dog following single oral administration. European Journal of Drug Metabolism and Pharmacokinetics. 17(4). 301–308. 10 indexed citations
18.
Shukla, Umesh, Sanjeev Kaul, P. Marathe, Kelly Pittman, & Rashmi H. Barbhaiya. (1992). Pharmacokinetics of nefazodone following multiple escalating oral doses in the dog. European Journal of Drug Metabolism and Pharmacokinetics. 17(4). 309–318. 7 indexed citations
19.
Marathe, P., et al.. (1991). Rhabdomyolysis and acute renal failure following a single dose of succinylcholine.. PubMed. 39(12). 968–70. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026